Photo taken from: Sarah Waliany/Twitter
Nov 23, 2023, 01:31
Sarah Waliany: The incomparable Sumanta K. Pal on cardiovascular AEs associated w/ mRCC treatments
Sarah Waliany, Hematology and Oncology Fellow at Dana-Farber Cancer Institute, made the following post on Twitter:
“The incomparable Sumanta K. Pal on cardiovascular AEs associated w/ mRCC treatments
Treatment landscape & key trials for mRCC
Treatment decisions in setting of CV comorbidities & tradeoffs
Future directions (HIF2 inhibitors, cellular therapies, bispecific Ab)”
For details click here.
Source: Sarah Waliany/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 17, 2024, 18:48
Sep 17, 2024, 18:42
Sep 17, 2024, 18:36
Sep 17, 2024, 18:18
Sep 17, 2024, 17:05
Sep 17, 2024, 16:48
Sep 17, 2024, 16:42
Sep 17, 2024, 16:40
Sep 17, 2024, 16:34